Ketamine derivative
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
105
NCT05414422
A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 1, 2022
Completion: Nov 10, 2022
NCT06232291
Observation of Safety and Tolerability Within 1 Year of the Use of R-ketamine / Placebo in Drug-resistant Depression
Phase: N/A
Role: Collaborator
Start: Apr 21, 2023
Completion: May 24, 2024
Loading map...